remission of delusions in patients with schizophrenia - a clinical pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004579

Enrollment

Registered

2012-11-27

Start date

2012-11-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20

Interventions

Group 1: Patientens with schizophrenia will be examined with diagnostic instruments (PANSS, SCL-90, RAS) und two qualitative Interviews.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: diagnosis F20.x

Exclusion criteria

Exclusion criteria: without delusional symptoms in the former acute stadium

Design outcomes

Primary

Measure	Time frame
persistent remission of symptoms (psychopathology with PANSS, SCL-90-R, structure of subjective experience with two semistrutured interviews).	—

Secondary

Measure	Time frame
sufficient quality of life and recovery (RAS-scale).	—

Countries

Germany

Contacts

Public ContactBurkhart Brückner

Hochschule Niederrhein

burkhart.brueckner@hs-niederrhein.de02161-186-5643

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026